CMP Stock Overview
Compumedics Limited engages in the research, development, manufacturing, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the Americas, Europe, and the Middle East.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Compumedics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.28 |
52 Week High | AU$0.44 |
52 Week Low | AU$0.14 |
Beta | 1.15 |
1 Month Change | -9.68% |
3 Month Change | -5.08% |
1 Year Change | 86.67% |
3 Year Change | -35.63% |
5 Year Change | -36.36% |
Change since IPO | 154.55% |
Recent News & Updates
Recent updates
Shareholder Returns
CMP | AU Medical Equipment | AU Market | |
---|---|---|---|
7D | 3.7% | 1.0% | 1.7% |
1Y | 86.7% | 26.8% | 12.9% |
Return vs Industry: CMP exceeded the Australian Medical Equipment industry which returned 26.8% over the past year.
Return vs Market: CMP exceeded the Australian Market which returned 12.9% over the past year.
Price Volatility
CMP volatility | |
---|---|
CMP Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 11.3% |
Market Average Movement | 8.8% |
10% most volatile stocks in AU Market | 17.3% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: CMP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine CMP's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 135 | David Burton | https://www.compumedics.com.au |
Compumedics Limited engages in the research, development, manufacturing, and distribution of medical equipment and related technologies in Australia, the Asia Pacific, the Americas, Europe, and the Middle East. It provides sleep diagnostics products, including Somfit/Somfit Pro, a wearable device for collecting patients’ physiological data; Somté PSG; Okti; Grael PSG; Grael DC; Falcon HST; Somté, an investigative tool; and Somté PSG. The company also offers neurology diagnostics, such as ONsight A.V.S. for monitoring patient's home ambulatory studies; Grael 4K PSG:EEG amplifiers; Grael 4K-EEG amplifiers; Grael LT EEG System amplifiers; Neuvo 64-512 Channel LTM EEG monitoring systems; Okti, an portable EEG amplifier; and Siesta 802, a multi-functional ambulatory recording device.
Compumedics Limited Fundamentals Summary
CMP fundamental statistics | |
---|---|
Market cap | AU$49.61m |
Earnings (TTM) | AU$1.23m |
Revenue (TTM) | AU$50.13m |
41.0x
P/E Ratio1.0x
P/S RatioIs CMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CMP income statement (TTM) | |
---|---|
Revenue | AU$50.13m |
Cost of Revenue | AU$23.05m |
Gross Profit | AU$27.08m |
Other Expenses | AU$25.85m |
Earnings | AU$1.23m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.007 |
Gross Margin | 54.02% |
Net Profit Margin | 2.46% |
Debt/Equity Ratio | 41.9% |
How did CMP perform over the long term?
See historical performance and comparison